» Authors » Ester Esteban-De Antonio

Ester Esteban-De Antonio

Explore the profile of Ester Esteban-De Antonio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Sanchez A, Sotolongo-Grau O, Tartari J, Sanabria A, Esteban-De Antonio E, Perez-Cordon A, et al.
Alzheimers Res Ther . 2024 Feb; 16(1):42. PMID: 38378643
Introduction: Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial...
2.
Morato X, Marquie M, Tartari J, Lafuente A, Abdelnour C, Alegret M, et al.
Sci Rep . 2023 Apr; 13(1):5406. PMID: 37012306
Although beta-amyloid (Aβ) and phosphorylated tau remain the preferred targets for disease-modifying treatments (DMT) against Alzheimer's disease (AD), part of the pathophysiological mechanisms of cognitive impairment are related to neuroinflammation...
3.
Marquie M, Garcia-Sanchez A, Alarcon-Martin E, Martinez J, Castilla-Marti M, Castilla-Marti L, et al.
Front Neurosci . 2023 Mar; 17:1076177. PMID: 36908784
Background: Optical coherence tomography angiography (OCT-A) is a novel method in the dementia field that allows the detection of retinal vascular changes. The comparison of OCT-A measures with established Alzheimer's...
4.
Marquie M, Garcia-Gutierrez F, Orellana A, Montrreal L, de Rojas I, Garcia-Gonzalez P, et al.
Int J Mol Sci . 2023 Jan; 24(2). PMID: 36674881
Few studies have addressed the impact of the association between Alzheimer's disease (AD) biomarkers and NPSs in the conversion to dementia in patients with mild cognitive impairment (MCI), and no...
5.
Marquie M, Valero S, Martinez J, Alarcon-Martin E, Garcia-Sanchez A, de Rojas I, et al.
Sci Rep . 2022 Oct; 12(1):16938. PMID: 36209290
Optical coherence tomography angiography (OCT-A) allows the detection of retinal vessel density (VD) loss, which is a reflection of brain vascular pathology. We aimed to investigate differences in macular VD...
6.
Orellana A, Garcia-Gonzalez P, Valero S, Montrreal L, de Rojas I, Hernandez I, et al.
Int J Mol Sci . 2022 Jul; 23(13). PMID: 35805894
Background: Clinical diagnosis of Alzheimer's disease (AD) increasingly incorporates CSF biomarkers. However, due to the intrinsic variability of the immunodetection techniques used to measure these biomarkers, establishing in-house cutoffs defining...
7.
Martino Adami P, Orellana A, Garcia P, Kleineidam L, Alarcon-Martin E, Montrreal L, et al.
Brain . 2022 Jan; 145(7):2507-2517. PMID: 35088840
Alzheimer's disease has a long asymptomatic phase that offers a substantial time window for intervention. Using this window of opportunity will require early diagnostic and prognostic biomarkers to detect Alzheimer's...
8.
Valero S, Marquie M, de Rojas I, Espinosa A, Moreno-Grau S, Orellana A, et al.
Sci Rep . 2021 Feb; 11(1):4762. PMID: 33619297
No abstract available.
9.
Valero S, Marquie M, de Rojas I, Espinosa A, Moreno-Grau S, Orellana A, et al.
Sci Rep . 2020 Nov; 10(1):20058. PMID: 33208795
To date, very few studies have been focused on the impact of the convergence of neuropsychiatric symptoms (NPS) and APOE ε4 on the conversion to dementia in patients with Mild...
10.
Marquie M, Valero S, Castilla-Marti M, Martinez J, Rodriguez-Gomez O, Sanabria A, et al.
Alzheimers Res Ther . 2020 Apr; 12(1):37. PMID: 32234080
Background: Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease...